Serological clues to survival in HIV-related cryptococcal meningitis
Official title: Serological correlates of survival in HIV-associated cryptococcal meningitis
Funded at Albert Einstein College of Medicine · NIH-11432319 · Data updated 2026-11-12
This grant looks for antibody signals in the blood that could predict who survives cryptococcal meningitis in people with HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | August 3, 2026 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $776,872 |
| NIH project number | 1R01AI201480-01 |
| Project ID | NIH-11432319 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with HIV who develop cryptococcal meningitis and are receiving standard antifungal and HIV therapies.
✕Less likely to help
Patients without cryptococcal meningitis or without HIV-related CNS disease may not benefit.
What this research studies
If you have HIV and develop cryptococcal meningitis, doctors want better ways to know who is at higher risk of dying and how to tailor treatment. The project will measure specific blood proteins called immunoglobulins to see if they relate to survival and response to therapy. By linking immune markers with outcomes, researchers hope to guide treatment choices and identify patients who may need intensified or different care. The work builds on past trials of antifungal regimens and aims to translate immune insights into practical, patient-centered decisions.
Why it matters
Potential benefit: If successful, this work could help clinicians personalize treatment for cryptococcal meningitis in people with HIV, potentially improving survival.
How similar studies have gone: Past large trials have informed treatment choices, but correlates of survival in this context are not yet established.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Pirofski, Liise-Anne — Albert Einstein College of Medicine
- Study coordinator: Pirofski, Liise-Anne
Related research
Other NIH-funded projects on the same topics.
-
Personalized Immunomodulatory Therapy for HIV-related Cryptococcal Meningitis
A patient-focused study investigates a personalized treatment approach to improve outcomes for people with HIV who develop cryptococcal meningitis.
-
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
A study in Uganda aims to use faster, better tests and a new antifungal to help people with HIV who develop meningitis.
-
TB meningitis diagnostic test compare and cost study in sub-Saharan Africa
Researchers are testing a new CSF urine-based test (SILVAMP TB LAM) to improve diagnosis of TB meningitis in people with HIV, to help speed treatment and reduce death in Sub-Saharan Africa.
-
Minimally Invasive Sampling to Improve HIV-Associated M meningitis Diagnosis in Africa
A research study is testing easier, less invasive ways to diagnose meningitis in people living with HIV, with a focus on making diagnosis faster and more accurate in Africa and the US.
-
Understanding brain injury in kids with tuberculous meningitis (iThemba)
A study in children with TB meningitis in South Africa will look at how inflammation and blood-clotting factors relate to brain injury and infarcts.
-
Blood-brain barrier problems during bacterial meningitis
Researchers are studying why the brain’s protective barrier fails during bacterial meningitis and how that leads to brain injury, with a focus on how bacteria invade brain cells and disrupt protective transporters.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.